IngenioRx, Anthem's pharmacy benefit manager, had an operating revenue of $5.9 billion in the first quarter of 2021, up 12.8 percent year over year, according to recent financial statements.
Five other numbers that show the unit's growth:
1. IngenioRx had an operating gain of $407 million in the three months ended March 31, up 16.6 percent from the same period a year before.
2. The PBM reflects 18.3 percent of Anthem's first-quarter operating revenue.
3. IngenioRx's operating margin was 6.9 percent in the first quarter of this year, up from 6.7 percent in the first quarter of 2020.
Subscribe to the following topics: anthem